chr13-45151724-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004128.3(GTF2F2):āc.197A>Gā(p.His66Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,606,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2F2 | NM_004128.3 | c.197A>G | p.His66Arg | missense_variant | 4/8 | ENST00000340473.8 | NP_004119.1 | |
GTF2F2 | XM_011535052.4 | c.197A>G | p.His66Arg | missense_variant | 4/9 | XP_011533354.1 | ||
GTF2F2 | XM_011535053.4 | c.197A>G | p.His66Arg | missense_variant | 4/6 | XP_011533355.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2F2 | ENST00000340473.8 | c.197A>G | p.His66Arg | missense_variant | 4/8 | 1 | NM_004128.3 | ENSP00000340823 | P1 | |
GTF2F2 | ENST00000706694.1 | c.26A>G | p.His9Arg | missense_variant, NMD_transcript_variant | 1/6 | ENSP00000516507 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152152Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000485 AC: 121AN: 249300Hom.: 0 AF XY: 0.000467 AC XY: 63AN XY: 134760
GnomAD4 exome AF: 0.000182 AC: 264AN: 1454458Hom.: 0 Cov.: 28 AF XY: 0.000192 AC XY: 139AN XY: 723920
GnomAD4 genome AF: 0.000493 AC: 75AN: 152268Hom.: 0 Cov.: 31 AF XY: 0.000618 AC XY: 46AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.197A>G (p.H66R) alteration is located in exon 4 (coding exon 4) of the GTF2F2 gene. This alteration results from a A to G substitution at nucleotide position 197, causing the histidine (H) at amino acid position 66 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at